Denmark
· Delayed Price · Currency is DKK Novonesis Company Description
Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally.
The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions.
Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions.
Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.
| Country | Denmark |
| Founded | 1925 |
| Industry | Specialty Chemicals |
| Sector | Materials |
| Employees | 6,756 |
| CEO | Ester Baiget |
Contact Details
Address: Krogshoejvej 36 Bagsvaerd, 2880 Denmark | |
| Phone | 45 44 46 00 00 |
| Website | novonesis.com |
Stock Details
| Ticker Symbol | NSIS.B |
| Exchange | Copenhagen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | DK0060336014 |
| SIC Code | 2890 |
Key Executives
| Name | Position |
|---|---|
| Ester Baiget | President and Chief Executive Officer |
| Rainer Lehmann | Executive Vice President and Chief Financial Officer |
| Anders Lund | Chief Operating Officer |
| Claus Crone Fuglsang | Chief Scientific Officer |
| Tobias Cornelius Bjorklund | Head of Investor Relations |
| Tue Micheelsen | Vice President of Global Sales and Marketing |
| Morten Enggaard Rasmussen | Executive Vice President of People and Stakeholder Relations |
| Tina Sejersgaard Fano | Executive Vice President of Planetary Health Biosolutions |
| Amy Byrick | Executive Vice President of Human Health Biosolutions |
| Henrik Joerck Nielsen | Executive Vice President of Strategy and Integration |